Stiles Financial Services Inc Sells 709 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Stiles Financial Services Inc trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 20.8% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,697 shares of the healthcare conglomerate’s stock after selling 709 shares during the period. Stiles Financial Services Inc’s holdings in UnitedHealth Group were worth $1,413,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in UNH. NewSquare Capital LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth $26,000. Hurley Capital LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth $28,000. Aster Capital Management DIFC Ltd acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth $30,000. Finally, Promus Capital LLC acquired a new position in UnitedHealth Group during the 4th quarter valued at $32,000. 87.86% of the stock is owned by institutional investors.

Analysts Set New Price Targets

UNH has been the subject of several research analyst reports. Oppenheimer cut their target price on shares of UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating for the company in a research note on Wednesday, May 14th. JPMorgan Chase & Co. upped their target price on shares of UnitedHealth Group from $405.00 to $418.00 and gave the company an “overweight” rating in a research note on Friday. TD Securities reiterated a “hold” rating and set a $308.00 target price (down from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Royal Bank Of Canada dropped their price objective on shares of UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating for the company in a research note on Friday, May 16th. Finally, Robert W. Baird cut shares of UnitedHealth Group from an “outperform” rating to a “neutral” rating and set a $312.00 price objective for the company. in a research note on Wednesday, June 11th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $427.09.

UnitedHealth Group Stock Down 1.7%

UNH opened at $302.04 on Monday. The firm’s 50-day simple moving average is $359.15 and its 200-day simple moving average is $461.96. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The firm has a market cap of $273.99 billion, a price-to-earnings ratio of 12.65, a PEG ratio of 1.42 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the prior year, the company earned $6.91 EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be issued a dividend of $2.21 per share. The ex-dividend date is Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.93%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s dividend payout ratio is currently 37.02%.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,533 shares of the business’s stock in a transaction on Wednesday, May 14th. The shares were bought at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the transaction, the director now owns 6,033 shares in the company, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director John H. Noseworthy bought 300 shares of the business’s stock in a transaction on Wednesday, May 14th. The shares were acquired at an average price of $312.16 per share, for a total transaction of $93,648.00. Following the completion of the transaction, the director now owns 6,063 shares in the company, valued at approximately $1,892,626.08. This trade represents a 5.21% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased a total of 109,408 shares of company stock valued at $31,607,768 in the last 90 days. 0.28% of the stock is currently owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.